Optimal control on a brain tumor growth model with lactate metabolism, viscoelastic effects, and tissue damage

Giulia Cavalleri, Alain Miranville · 2025

Read Optimal control on a brain tumor growth model with lactate metabolism, viscoelastic effects, and tissue damage by Giulia Cavalleri, Alain Miranville (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/arxiv-2503-17049.txt.

Introduction

Giulia Cavalleri and Alain Miranville study best control of a brain tumor growth model that joins lactate use, spring like tissue traits, and tissue harm. Control here means picking drug doses that steer the tumor best. Their work came out in twenty twenty-five.

The model links a spread equation for tumor cell density with one for lactate, a force balance for tissue shift, and a rule for harm growth. Two controls stand for chemo and a lactate targeted drug. The authors set a cost score for care, prove that best controls exist, and show how the state shifts when controls shift. They end with a first order rule that any best care plan must meet.

Catalog record

CREATORGiulia Cavalleri, Alain Miranville
YEAR2025
COLLECTIONPAPERS
FORMATTXT
FILE SIZE92 KB
VERSION1.0
LICENSEhttp://creativecommons.org/licenses/by/4.0/
RIGHTSCC BY
SOURCEarXiv

Source: https://arxiv.org/abs/2503-17049

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Optimal control on a brain tumor growth model with lactate metabolism, viscoelastic effects, and tissue damage Giulia Cavalleri, Alain Miranville Abstract In this paper, we study an optimal control problem for a brain tumor growth model that incorporates lactate metabolism, viscoelastic effects, and tissue damage. The PDE system, introduced in [ Cav+25 ] , couples a Fisher–Kolmogorov-type equation for tumor cell density with a reaction-diffusion equation for the lactate, a quasi-static force balance governing the displacement, and a nonlinear differential inclusion for tissue damage. The control variables, representing chemotherapy and a lactate-targeting drug, influence tumor progression and treatment response. Starting from well-posedness, regularity, and continuous dependence results proven in [ Cav+25 ] , we define a suitable cost functional and prove the existence of optimal controls. Then, we analyze the differentiability of the control-to-state operator and establish a necessary first-order condition for treatment optimality. Key words: tumor growth models, lactate kinetics, mechanical effects, damage, optimal control, adjoint system, necessary optimality conditions. AMS (MOS) Subject Classification: 35Q93, 49J20, 49K20, 35Q92, 92C50. 1 Introduction Primary brain tumors, especially gliomas and glioblastomas, are characterized by angiogenesis, invasive growth, and necrosis. Despite advances in medical research and treatment strategies, the brain tumor survival rate remains low (see, e.g., [ DC16 ] ), and no significant improvement has been observed recently (see, e.g., [ Szo+17 ] ). For this reason, it is crucial to explore new therapeutic approaches and to complement clinical studies with mathematical modeling. The aim of the latter is not only to predict the course of the disease, but also to optimize treatments, by adjusting the combination, timing, and dosage of therapies to achieve the best possible outcome for the patient, meaning maximum reduction of the tumor and minimum drug-related side effects. This is where the present contribution comes into play. Specifically, we are interested in a protocol that combines chemotherapy with a drug targeting lactate, which seems promising from an experimental point of view (cf. [ Son+08 ] , [ Tan+21 ] , [ Guy+22 ] ). From the mathematical perspective, only a few works go in this direction (see, e.g., [ Aub+05 ] , [ Clo+09 ] , [ Gui+18 ] , [ Che+21 ] , [ Che+22 ] ) and even fewer regard optimal control (cf. [ Che+24 ] ). This paper seeks to study an optimal control problem starting from the model recently proposed and analyzed in [ Cav+25 ] , which describes the dynamics of a brain tumor taking into account the lactate metabolism, viscoelastic effects of the tissue, and possible damage caused by surgery. The introduction of the damage variable in this context was inspired by [ Cav24 ] , by one of the authors of the present contribution, where damage was first incorporated into a tumor model. Among the huge literature regarding optimal control for tumor growth models (see, e.g., [ BAD15 ] , [ Col+21 ] , [ GL16 ] , [ GLR18 ] , [ EK19 ] , [ Sig20 ] , and the references cited therein) we would like to recall once again [ Che+24 ] , where the authors deal with a brain tumor-specific model. The resulting PDE system couples three parabolic equations, one for the tumor cell density, and the other two for the intracellular lactate concentration and the capillary lactate concentration, respectively. Another perspective related to the present work is the one from [ GLS21 ] , in which the authors consider a phase-field model of Cahn–Hilliard type taking into account the presence of a nutrient (such as oxygen or glucose) and mechanical effects. The model. Let \Omega be a bounded C^{2} domain in \mathbb{R}^{n} with n=2,3 and let \boldsymbol{\nu} be its outward unit normal to \partial\Omega . We are interested in the PDE system \displaystyle\partial_{t}\varphi-\Delta\varphi=U(\varphi,\sigma,z,\chi_{1}), (1.1a) \displaystyle\partial_{t}\sigma-\Delta\sigma+K(\varphi,\sigma,z)=\chi_{2}\color[rgb]{0,0,0}S(\varphi,z), (1.1b) \displaystyle-\diver\left[\mathcal{A}\varepsilon(\partial_{t}\boldsymbol{u})+\mathcal{B}(\varphi,z)\varepsilon(\boldsymbol{u})\right]=\boldsymbol{f}, (1.1c) \displaystyle\partial_{t}z-\Delta z+\beta(z)+\pi(z)\ni\iota-\Psi(\varphi,\varepsilon(\boldsymbol{u})), (1.1d) posed in the parabolic cylinder Q\coloneqq\Omega\times(0,T) , where the domain \Omega represents the brain and the fixed time T>0 is the medical treatment duration. In equations ( 1.1a ) and ( 1.1b ) we introduced the notation K(\varphi,\sigma,z)\coloneqq\frac{k_{1}(\varphi,z)\sigma}{k_{2}(\varphi,z)+\sigma},\quad U(\varphi,\sigma,z,\chi_{1})\coloneqq(p(\sigma,z)-\chi_{1}\color[rgb]{0,0,0})\varphi\left(1-\frac{\varphi}{N}\right)-\varphi g(\sigma,z) for the sake of brevity. As already pointed out, a slightly modified version of ( 1.1 ) was proposed in [ Cav+25 ] . We refer the reader to it for further modeling details and recall only the most important aspects. The variable \varphi represents the tumor cell density and takes value in [0,N] , where the constant N is the fixed carrying capacity of the tissue. It is ruled by the Fischer–Kolmogorov type equation ( 1.1a ). The parabolic reaction-diffusion equation ( 1.1b ) governs the evolution of \sigma , which is the intracellular lactate concentration. The quasi-static balance of forces ( 1.1c ) for a viscoelastic tissue describes the dynamic of \boldsymbol{u} , which is the small displacement field of each point with respect to a reference undeformed configuration. The local tissue damage z takes value in the interval [0,1] , where z=0 means there is no damage while z=1 means that the tissue is totally damaged. Its evolution is ruled by the parabolic differential inclusion ( 1.1d ). Finally, \chi_{1} is the concentration of a cytotoxic drug, which decreases the tumor proliferation p(\sigma,z) in the mass source U . Similarly, the term \chi_{2} represents a lactate targeting drug and affects the lactate source term S . The system ( 1.1 ) is coupled with the boundary conditions \displaystyle\partial_{\boldsymbol{\nu}}\varphi=\partial_{\boldsymbol{\nu}}z=0, (1.2a) \displaystyle\partial_{\boldsymbol{\nu}}\sigma=\sigma_{\Gamma}-\sigma, (1.2b) \displaystyle\boldsymbol{u}=\mathbf{0}, (1.2c) and the initial conditions \varphi(0)=\varphi_{0},\quad\sigma(0)=\sigma_{0},\quad\boldsymbol{u}(0)=\boldsymbol{u}_{0},\quad z(0)=z_{0}. (1.3) The cost functional. Introducing the notation \boldsymbol{\chi}=(\chi_{1},\chi_{2}) , we define the following cost functional \begin{split}\mathcal{J}((\varphi,\sigma,\boldsymbol{u},z),\boldsymbol{\chi})\coloneqq&\frac{\alpha_{1}}{2}\lVert\varphi-\varphi_{Q}\rVert_{L^{2}(Q)}^{2}+\frac{\alpha_{2}}{2}\lVert\varphi(T)-\varphi_{\Omega}\rVert_{H}^{2}+\alpha_{3}\int_{\Omega}\varphi(T)\,\mathrm{d}x\,\\ &+\frac{\alpha_{4}}{2}\lVert\sigma-\sigma_{Q}\rVert_{L^{2}(Q)}^{2}+\frac{\alpha_{5}}{2}\lVert\sigma(T)-\sigma_{\Omega}\rVert_{H}^{2}\\ &+\frac{\alpha_{6}}{2}\lVert\sqrt{\gamma(\varphi)}\varepsilon(\boldsymbol{u})\rVert_{L^{2}(Q)}^{2}+\frac{\alpha_{7}}{2}\lVert z-z_{Q}\rVert_{L^{2}(Q)}^{2}\\ &+\alpha_{8}\int_{\Omega}z(T)\,\mathrm{d}x\,+\frac{\alpha_{9}}{2}\lVert\boldsymbol{\chi}\rVert_{L^{2}(Q)}^{2}.\end{split} (1.4) The non-negative constants \alpha_{1},\dots,\alpha_{9} are weights that can not vanish all at the same time, while \varphi_{Q} , \varphi_{\Omega} , \sigma_{Q} , \sigma_{\Omega} , z_{Q} are target functions. More explicitly, the term \varphi_{Q} (resp. \sigma_{Q} , z_{Q} ) is a desired evolution for the tumor (resp. the lactate, the damage), while \varphi_{\Omega} (resp. \sigma_{\Omega} ) is a desired final configuration of the tumor (resp. concentration of the lactate). The third and eighth addends measure the size of the tumor and the magnitude of the damage at the end of the treatment. Since the presence of high mechanical stress, especially in certain areas of the brain, can compromise its functionality, we are interested in keeping it low. The sixth term serves this purpose, and \gamma may be, for instance, the indicator function of a subdomain of \Omega where the stress is intended to remain low. Finally, the last addend is a L^{2} regularization for the controls. We are interested in studying the minimizers of the cost functional ( 1.4 ) subject to the PDE system ( 1.1 )–( 1.3 ) and constrained to a suitable admissible control set. We define it as \mathcal{U}_{\text{ad}}=\mathcal{U}_{\text{ad}}^{1}\times\mathcal{U}_{\text{ad}}^{2} with \begin{split}&\mathcal{U}_{\text{ad}}^{1}\coloneqq\{\chi_{1}\in L^{2}(V)\cap L^{\infty}(Q)\,\mathrel{\mathop{\mathchar 58\relax}}\,\lVert\chi_{1}\rVert_{L^{2}(V)}\leq C_{\text{ad}},\,\,\underline{\chi_{1}}\leq\chi_{1}\leq\overline{\chi_{1}}\text{ a.e.}\},\\ &\mathcal{U}_{\text{ad}}^{2}\coloneqq\{\chi_{2}\in L^{\infty}(Q)\,\mathrel{\mathop{\mathchar 58\relax}}\,\underline{\chi_{2}}\leq\chi_{2}\leq\overline{\chi_{2}}\text{ a.e.}\},\end{split} where C_{\text{ad}}>0 is a fixed constant and \underline{\chi_{1}} , \overline{\chi_{1}} , \underline{\chi_{2}} , \overline{\chi_{2}}\in L^{\infty}(Q) are given threshold functions such that \mathcal{U}_{\text{ad}} is nonempty. The admissible control set \mathcal{U}_{\text{ad}} is a subset of \mathcal{U}=\mathcal{U}^{1}\times\mathcal{U}^{2}\coloneqq\left[L^{2}(V)\cap L^{\infty}(Q)\right]\times L^{\infty}(Q) equipped with its natural norm that we denote with \lVert\cdot\rVert_{\mathcal{U}} . Remark 1.1 . Notice that \mathcal{U}_{\text{ad}} is a nonempty, closed, and convex subset of \mathcal{U} . Moreover, there exists a positive constant

Read the complete text